Henan Taloph Pharmaceutical Stock Co.Ltd(600222)
Announcement on the early general election of the board of directors and the board of supervisors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
The term of office of the eighth board of directors and board of supervisors of Henan Taloph Pharmaceutical Stock Co.Ltd(600222) (hereinafter referred to as “the company”) will expire on September 9, 2022. In view of the change of the controlling shareholder and actual controller of the company, in order to further improve the corporate governance structure and ensure the effective decision-making and peaceful and stable development of the company, according to the company law of the people’s Republic of China According to the relevant provisions of laws and regulations such as the Listing Rules of Shanghai Stock Exchange, normative documents and the articles of association, it is decided to conduct the general election of the board of directors and the board of supervisors in advance. The specific situation is hereby announced as follows: I. General Election of the board of directors
The ninth board of directors of the company will be composed of 9 directors, including 6 non independent directors and 3 independent directors.
The company held the 22nd Meeting of the 8th board of directors on February 9, 2022, and deliberated and adopted the proposal on early replacement of the board of directors and election of non independent directors of the 9th board of directors and the proposal on early replacement of the board of directors and election of independent directors of the 9th board of directors. Upon the nomination of qualified shareholders and the board of directors and the qualification examination of the nomination committee of the board of directors, the list of candidates for directors of the ninth board of directors of the company is as follows (resume attached):
1. Mr. Yin Hui, Mr. Li Jingliang, Mr. Li Hui, Mr. Ma Shiguang, Ms. Chen Jinge and Mr. Chen siliang are candidates for non independent directors of the ninth board of directors of the company.
2. Mr. Yin Xiaohua, Mr. Fang Liang and Ms. Liu Yumin are candidates for independent directors of the ninth board of directors of the company.
Among the above three candidates for independent directors, Mr. Yin Xiaohua and Mr. Fang Liang have obtained the qualification certificate of independent directors, and Ms. Liu Yumin promises to participate in the latest training on the qualification of independent directors and obtain the qualification of independent directors recognized by Shanghai Stock Exchange. The qualifications of the above independent director candidates have been examined and approved by Shanghai Stock Exchange.
The current independent director agreed to the above proposal.
2、 General election of the board of supervisors
The ninth board of supervisors of the company will be composed of three supervisors, including two non employee representative supervisors and one employee representative supervisor.
The company held the 13th meeting of the 8th board of supervisors on February 9, 2022, deliberated and adopted the proposal on the early replacement of the board of supervisors and the election of non employee representative supervisors of the 9th board of supervisors. Upon nomination by qualified shareholders, Mr. Zhang Zhixian and Ms. Wang Yikun (resume attached) are candidates for non employee representative supervisors of the ninth board of supervisors of the company.
The above non employee representative supervisors will form the ninth board of supervisors together with Mr. Li rongpu, the employee representative supervisor elected by the company through the employee congress (resume attached). 3、 Other information
The company will hold the first extraordinary general meeting in 2022 to consider the general election of the board of directors and the board of supervisors, in which non independent directors, independent directors and non employee representative supervisors will be elected by cumulative voting. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) Notice on convening the first extraordinary general meeting of shareholders in 2022 (Announcement No.: Lin 2022-010) disclosed. The term of office of the directors and supervisors of the ninth board of directors of the company is three years, which takes effect from the date of deliberation and approval by the general meeting of shareholders.
In order to ensure the normal operation of the board of directors and the board of supervisors of the company, the eighth board of directors and the board of supervisors of the company will continue to perform their duties in accordance with the relevant provisions of the company law and the articles of association before the general meeting of shareholders of the company deliberates and approves the general election of the board of directors and the board of supervisors. The company expresses its heartfelt thanks to the members of the 8th board of directors and board of supervisors for their contributions to the company during their tenure.
It is hereby announced.
Attachment: resume of candidates
Henan Taloph Pharmaceutical Stock Co.Ltd(600222) board of directors February 10, 2022
enclosure:
Resume of candidates for board of directors and board of supervisors
Yin Hui: male, born in August 1965, CPC member, bachelor degree, senior engineer. He has successively served as the chairman of Zhengzhou high tech Municipal Construction Co., Ltd. and is now the party secretary and chairman of Zhengzhou High Tech Investment Holding Group Co., Ltd.
Li Jingliang: male, born in January 1969, with a graduate degree. He has successively served as the general manager and vice chairman of the company and the chairman of Zhengzhou Zhongsheng Industrial Group Co., Ltd. He is currently the chairman of the company.
Li Hui: male, born in May 1972, a member of China Democratic Construction Association, with a postgraduate degree. He has successively served as the financial director, Secretary of the board of directors, executive deputy general manager and general manager of the company. He is currently the chairman of Tailong Health Industry Investment Co., Ltd., the director and vice chairman of the company.
Ma Shiguang: male, born in December 1975, Party member of the Communist Party of China, graduate degree. He has successively served as the chief economist of Zhengzhou high tech investment and Construction Group Co., Ltd. He is now the general manager of Zhengzhou High Tech Investment Holding Group Co., Ltd.
Chen Jinge: female, born in July 1978, member of the Communist Party of China, graduate degree, senior financial planner. He has successively served as the general manager of Zhengzhou high tech Fudi Landscaping Engineering Co., Ltd. and is now the organization member, director and general manager of the general Party branch of Zhengzhou high Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Investment Group Co., Ltd. Chen siliang: male, born in November 1977, member of the Communist Party of China, graduate degree, auditor, cost engineer and senior accountant. He has successively served as the deputy director of the Audit Department of the special commissioner’s office of the National Audit Office in Zhengzhou. He is currently a member of the Party committee, Secretary of the Discipline Inspection Commission and deputy general manager of Zhengzhou High Tech Investment Holding Group Co., Ltd.
Yin Xiaohua: male, born in November 1953, bachelor degree, non practicing member of China Institute of certified public accountants. He has successively served as associate professor of Business School of Zhengzhou University, Central Plains Environment Protection Co.Ltd(000544) , Sanquan Food Co.Ltd(002216) , independent director of Hanwei electronics, Huaying agriculture and Henan diamond. Currently Yutong Bus Co.Ltd(600066) , Henan Shuanghui Investment & Development Co.Ltd(000895) , independent director of the company.
Fang Liang: male, born in March 1963, with a graduate degree and a senior manager. He has successively served as general manager of Shanghai Leishi Pharmaceutical Co., Ltd., deputy general manager of Shanghai leiyunshang Pharmaceutical Co., Ltd. and general manager of Shanghai Guochuang Pharmaceutical Co., Ltd. He is currently the chairman of Shanghai jiuhetang traditional Chinese Medicine Co., Ltd., the executive president of Shanghai jiuhetang traditional Chinese Medicine Co., Ltd. and an independent director of the company.
Liu Yumin: female, born in November 1956, member of the Communist Party of China, with a doctor’s degree. He has successively served as lecturer, associate professor and professor of Zhengzhou Institute of aviation industry management. He is currently a professor and doctoral supervisor of the Business School of Zhengzhou University.
Zhang Zhixian: male, born in November 1973, member of the Communist Party of China, university degree. He has successively served as the financial director of Zhengzhou Zhongsheng Industrial Group Co., Ltd. He is currently the chairman of Zhengzhou Zhongsheng Industrial Group Co., Ltd. and the chairman of the board of supervisors of the company.
Wang Yikun: female, born in May 1979, CPC member, bachelor degree, registered consultant. He has successively served as vice chairman of the labor union and deputy manager of the investment management department of Zhengzhou high tech investment and Construction Group Co., Ltd. Currently, he is the manager of the operation and Management Department of Zhengzhou high Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) Investment Group Co., Ltd.
Li rongpu: male, born in May 1965, member of the Communist Party of China, university degree. He has successively served as the workshop director of the company’s Yuzhong pharmaceutical factory, and is now the Secretary of the Party branch and the assistant to the factory director of the company’s Yuzhong pharmaceutical factory.
